Results 111 to 120 of about 8,134 (194)

Refractory hyponatremia in small cell lung cancer: a case report and literature review. [PDF]

Front Endocrinol (Lausanne)
Bao S, Qin L, Zhang Y, Jiang X, Duan L.
europepmc   +1 more source

Real-World Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Therapy in Nondiabetic Autosomal-Dominant Polycystic Kidney Disease: Effects on Progression to Dialysis in a TrinetX Cohort. [PDF]

Mayo Clin Proc Innov Qual Outcomes
Chang CH, Kuo YC, Kuan YH, Lim PS, Chung MC, Pan YR, Luo CW, Wu TK.   +7 more
europepmc   +1 more source

Eight Years of Canadian Real-World Assessment of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease: The C-MAJOR Registry. [PDF]

Can J Kidney Health Dis
McFarlane P, Bichet DG, Alam A, Bubolic S, Laplante A.   +4 more
europepmc   +1 more source

Tolvaptan vs Fluid Restriction in Moderate-Profound Hyponatremia: An Open-Label Randomized Clinical Trial. [PDF]

J Clin Endocrinol Metab
Warren AM, Grossmann M, Hoermann R, Lin R, Zajac JD, Russell N.   +5 more
europepmc   +1 more source

Efficacy of Low-Dose Tolvaptan for Treatment of Profound Hyponatremia in Syndrome of Inappropriate Antidiuresis (SIAD): The EFFLUX-FLUID TRIAL. [PDF]

Kidney Med
Jaiyen N, Chinpraditsuk S, Pattharanitima P, Tantiyavarong P, Krisanapan P.   +4 more
europepmc   +1 more source

No relationship between total kindey volume class or genotype and 24h blood pressure control in adult ADPKD patients [PDF]

, 2018
Allamani, Mandelina, Devos, Hannes, Schots, Lisa, Tonnelier, Annelies, Van der Niepen, Patricia   +4 more
core   +2 more sources

Comparative Strategies to Overcome Diuretic Resistance in Heart Failure: A Network Meta-Analysis. [PDF]

JACC Adv
Lima IG, Nunes JT, Luk AC, Brahmbhatt DH, Godoy LC, McDonald M, Billia F, Bocchi EA.   +7 more
europepmc   +1 more source

Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis [PDF]

, 2016
Angelique Sao-Mai Do, Beth Vogt, Bruce Berger, Karin Herrmann, Katherine Dell, Linda Lou, Michael Simonson, Pauravi Vasavada, Robert Cunningham, Rupesh Raina   +9 more
core   +1 more source

Tolvaptan pharmacokinetics and pharmacodynamics in adolescents with autosomal dominant polycystic kidney disease. [PDF]

Eur J Pediatr
Shoaf SE, Sikes K.
europepmc   +1 more source

SAR-Guided Scaffold Innovation of Selective V₂R Antagonists: Therapeutic Frontiers in ADPKD. [PDF]

ACS Med Chem Lett
Shi H, Li Y, Liang SH.
europepmc   +1 more source